Kyle R. Brownback, MD

NPI 1619192291ActiveIndividual· Internal Medicine, Pulmonary Disease· Kansas City, KS

Internal Medicine, Pulmonary Disease (MD) in Kansas City, Kansas, trained at University of Kansas School of Med (Kc/Wich/Sal) (class of 2006). Their prescriptions cost Medicare Part D more than their services did: $358,637 for 584 claims, against $60,120 paid for services in 2024. Pulmonx Corporation reported $160.71 in payments in 2025, mostly food and beverage.

Overview

NPI	1619192291
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Apr 17, 2007
Last updated in NPPES	Nov 2, 2023
Certified by provider	Nov 2, 2023

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Pulmonary Disease Primary	207RP1001X	04-34217	KS
Internal Medicine	207R00000X	LP008845	RI
Internal Medicine, Critical Care Medicine	207RC0200X	04-34217	KS

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026	No match	—
New York OMIG · Nov 4, 2026	No match	—
Ohio Medicaid · Nov 4, 2026	No match	—
Pennsylvania Medicheck · Nov 4, 2026	No match	—
Washington HCA · Nov 4, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Pulmonary Disease (KS)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	459
Services billed	1,074 across 39 procedure codes
Paid by Medicare	$60,120

Part D prescriptions in 2024

Prescriptions (claims)	584 · 922 30-day fills
Patients	112
Total drug cost	$358,637
Generic share	33% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Kansas School of Med (Kc/Wich/Sal)
Graduation year	2006
Medicare specialty	Pulmonary Disease
Secondary specialties	Critical Care (Intensivists)
Telehealth	Offers telehealth